Clinical value of detecting autoantibodies against β(1)-, β(2),- and α(1)-adrenergic receptors in carvedilol treatment of patients with heart failure

OBJECTIVE: To determine the possible association of anti-β(1)-adrenergic receptors (anti-β(1)-AR), anti-β(2)-AR and anti-α(1)-AR with carvedilol treatment in patients with heart failure (HF). METHODS: A total of 267 HF patients were prospectively enrolled. Blood samples were measured by an enzyme-li...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Dong-Yan, Xu, Lin, Zhang, Zhi-Yong, Xu, Xiao-Rong, Wang, Xin, Zhang, Juan, Liu, Jia-Mei, Wang, Hua, Chen, Jin, Zhang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338933/
https://www.ncbi.nlm.nih.gov/pubmed/32670360
http://dx.doi.org/10.11909/j.issn.1671-5411.2020.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338933/
https://www.ncbi.nlm.nih.gov/pubmed/32670360
http://dx.doi.org/10.11909/j.issn.1671-5411.2020.06.002

Ejemplares similares